 Theravance Inc  USA Stock   9.81 0.00 0.00% 
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Also please take a look at
World Market Map.
Z Score Analysis
ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..
Theravance  Z Score  =  Sum Of   5 Factors 
 =  4.2  
 First Factor  =  1.2 * (  Working Capital  /  Total Assets ) 

 Second Factor  =  1.4 * (  Retained Earnings  /  Total Assets ) 

 Thrid Factor  =  3.3 * (  EBITAD  /  Total Assets ) 

 Fouth Factor  =  0.6 * (  Market Value of Equity  /  Total Liabilities ) 

 Fifth Factor  =  0.99 * (  Revenue  /  Total Assets ) 

About Z Score
To calculate ZScore one would need to know current working capital of the company, its total assets and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1 indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition Theravance Inc has Z Score of 4.2. This is much lower than that of the sector, and significantly lower than that of Z Score industry, The Z Score for all stocks is over 1000% higher than the company.